AMENDMENT Solicitation Integrated Immunoassay and Chemistry Analyzer Reagents and Consumables

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

W40M MRC0 WEST

Contract Value

Not provided

Codes & Classification
Solicitation Number

W81K0026QA042

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

Fort Rucker, Alabama, UNITED STATES

SourceSAM
Documents5
The U.S. Army Medical Command (MEDCOM), through the contracting office W40M MRC0 WEST, has issued an amended Sources Sought notice for the procurement of reagents and consumables compatible with integrated immunoassay and chemistry analyzers. This procurement activity, now referenced under solicitation number W81K0026QA048 (previously W81K0026QA042), is intended to support laboratory operations at Fort Rucker, Alabama. The primary objective of this solicitation is to identify qualified sources capable of supplying high-quality in-vitro diagnostic reagents and consumables necessary for the operation of integrated immunoassay and chemistry analyzers. These materials are essential for conducting a wide range of diagnostic tests, supporting the medical readiness and healthcare delivery for personnel at Fort Rucker. The scope of the requirement encompasses the consistent and timely provision of these specialized products, ensuring uninterrupted laboratory services. Key requirements include the ability to manufacture or supply in-vitro diagnostic substances, as classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing, 2022 version), and Product Service Code 6550. Prospective contractors must demonstrate compliance with all applicable regulatory standards and provide documentation as outlined in the solicitation instructions and Exhibit A, which details the Defense Health Agency (DHA) Risk Management Framework (RMF) requirements. Deliverables are expected to include all necessary reagents and consumables compatible with the specified analyzers, with a focus on quality, reliability, and compatibility. The place of performance for this contract is Fort Rucker, Alabama, United States. The contracting activity is a federal office, and all correspondence regarding this opportunity should be directed to the primary contact, Karan E. Quiles ([email protected]), or the secondary contact, Fredicinda D. Jones ([email protected]). This notice is classified as a Sources Sought, indicating that the government is conducting market research to determine the availability and capability of potential sources prior to issuing a formal solicitation. Contractors are encouraged to review the solicitation instructions and attached documents for detailed requirements and to respond by the specified deadline of January 16, 2026. No set-aside requirements or special considerations have been specified in the notice. Contractors with expertise in the manufacturing or supply of in-vitro diagnostic substances and experience supporting military or federal healthcare facilities are particularly encouraged to respond. For further information and access to the solicitation and attachments, interested parties should refer to the official posting on SAM.gov at https://sam.gov/opp/9871982e1b874c51874ff4de1130bda3/view. This opportunity represents a critical support function for military healthcare operations and offers qualified vendors the chance to contribute to the readiness and health of service members at Fort Rucker.